Literature DB >> 1677039

Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors.

A N Schoffelmeer1, G Warden, F Hogenboom, A H Mulder.   

Abstract

In the presence of physiological cations (in Krebs-4-(2-hydroxyethyl)-1- piperazineethanesulfonic acid buffer) at 37 degrees C the Ki value's of beta-endorphin for mu- and delta-opioid receptor binding sites in rat neocortical membranes, labeled with [3H][D-Ala2,MePhe4,Gly- ol5]enkephalin (DAMGO) and [3H][D-Ala2-D-Leu5]enkephalin (in the presence of unlabeled DAMGO), respectively, amounted to about 9 and 22 nM. Surprisingly, a very different selectivity pattern for the endogenous opioid peptide was found when the affinity of beta-endorphin for functional presynaptic opioid receptors was examined. Thus, beta-endorphin strongly inhibited the electrically evoked release of [3H]NE from rat neocortical slices with an IC50 value of about 0.5 nM, whereas [14C] acetylcholine release from neostriatal slices was inhibited with an IC50 value of about 100 nM. On the other hand, the electrically evoked release of [3H]dopamine from striatal slices was not affected by beta-endorphin. The inhibitory effects of DAMGO and beta-endorphin on [3H]NE release from neocortical slices were equally well antagonized by naloxone. Moreover, 10 nM of the highly selective mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen- Thr-NH2 antagonized competitively the inhibitory effect of beta-endorphin on [3H]NE release.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1677039

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Role of cholinergic and GABAergic neurotransmission in the opioids-mediated GnRH release mechanism of EBP-primed OVX rats.

Authors:  G Kaur; G Kaur
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Challenges and new opportunities for detecting endogenous opioid peptides in reward.

Authors:  Sineadh M Conway; Marwa O Mikati; Ream Al-Hasani
Journal:  Addict Neurosci       Date:  2022-04-03

3.  Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.

Authors:  Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

Review 4.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Biased signaling by endogenous opioid peptides.

Authors:  Ivone Gomes; Salvador Sierra; Lindsay Lueptow; Achla Gupta; Shawn Gouty; Elyssa B Margolis; Brian M Cox; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

6.  Skin β-endorphin mediates addiction to UV light.

Authors:  Gillian L Fell; Kathleen C Robinson; Jianren Mao; Clifford J Woolf; David E Fisher
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

Review 7.  Skin pigmentation and its control: From ultraviolet radiation to stem cells.

Authors:  Joseph Michael Yardman-Frank; David E Fisher
Journal:  Exp Dermatol       Date:  2020-12-24       Impact factor: 3.960

8.  Testosterone modulation of ethanol effects on the µ-opioid receptor kinetics in castrated rats.

Authors:  Rafaat Khalil; Jessica Humann
Journal:  Biomed Rep       Date:  2019-07-18

9.  Regulation of Opioid Receptors by Their Endogenous Opioid Peptides.

Authors:  Achla Gupta; Srinivas Gullapalli; Hui Pan; Dinah L Ramos-Ortolaza; Michael D Hayward; Malcom J Low; John E Pintar; Lakshmi A Devi; Ivone Gomes
Journal:  Cell Mol Neurobiol       Date:  2021-01-02       Impact factor: 4.231

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.